Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Cancer Genetics Inc (NQ: CGIX)
1.100 USD  +0.070 (+6.80%)
Streaming Delayed Price  /  Updated: 8:00 AM EDT, Aug 16, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 100
Open 0.9600
Bid (Size) 0.7000 (4)
Ask (Size) 1.100 (5)
Prev. Close 1.030
Today's Range 0.9600 - 1.100
52wk Range 0.8220 - 3.750
Shares Outstanding 27,746,497
Dividend Yield N/A
Performance
YTD
-43.59%
-43.59%
1 Month
+27.17%
+27.17%
3 Month
+20.21%
+20.21%
6 Month
-38.89%
-38.89%
1 Year
-64.52%
-64.52%
Top News
More News
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
Conference call at 8:30 a.m. ET, Tuesday, August 14, 2018 Read More
from GlobeNewswire News Releases
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
Conference call at 8:30 a.m. EDT, Tuesday, August 14, 2018 Read More
from GlobeNewswire News Releases
More News
Read More
Cancer Genetics Closes $2.625 million Convertible Note Financing
from GlobeNewswire News Releases
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
from GlobeNewswire News Releases
FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018
from ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – CGIX
from ACCESSWIRE
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Cancer Genetics, Inc. (CGIX) and Encourages Investors to Contact the Firm Before June 4th
from GlobeNewswire News Releases
Safirstein Metcalf LLP Reminds Investors That A Class Action Has Been Filed Against Cancer Genetics, Inc. – CGIX
from GlobeNewswire News Releases
Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cancer Genetics, Inc. (CGIX)
from Business Wire News Releases
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018
from ACCESSWIRE
Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cancer Genetics, Inc. (CGIX)
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.